Third-Party Hardware Modification of Interventional X-Ray Equipment

WASHINGTON — AdvaMed, the Medtech Association, today announced that John Jaeckle, Chief Regulatory Affairs Strategist, at GE HealthCare, is the recipient of the 2026 AdvaMed Imaging Röntgen Award. The award recognizes Jaeckle’s more than 25 years of leadership in medical imaging regulation and standards development, including his work to advance computed tomography technology, performance and regulatory alignment in the United States and worldwide.

When is software not just software? That’s the question at the center of comments AdvaMed recently filed with the U.S. Copyright Office. At first glance, this may sound like a narrow dispute about medical device repair. In reality, it reflects a broader challenge facing a software-driven economy: how should the law treat software that is distinct from, but connected to, the products it supports?

WINNIPEG, MANITOBA, CANADA, August 20, 2026 /EINPresswire.com/ — Cubresa Inc., a global leader in clinical and preclinical molecular imaging technologies, today announced that it has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Cubresa BrainPET™ scanner.

GHENT, BELGIUM — XEOS, a medical technology company advancing intraoperative molecular imaging, today announced the publication of the BrIMA (Breast cancer Intraoperative Margin Assessment) study in JAMA Surgery, world’s leading peer reviewed surgical journals.  The prospective, multicenter clinical trial demonstrated that the specimen images obtained with the AURA 10® PET-CT system significantly improved surgeons’ ability to identify and address positive margins during breast-conserving surgery, providing actionable information at the point where surgical decisions are made.

EAGAN, Minn. – June 9, 2026 – Sonex Health, Inc. (Sonex Health) and The Institute of Advanced Ultrasound Guided Procedures today announced publication of six-month data demonstrating the safety and efficacy of ultrasound-guided carpal tunnel release (UGCTR) using UltraGuideCTR™. The study, published in the Journal of Hand Surgery Global Online, represents the largest prospective evaluation of UGCTR to date.

Millions of patients’ lives are improved every day because of advancements in medical technology. But too often, gaps in coverage and access prevent patients from benefiting from the safe, effective, and innovative technologies that can help detect disease earlier, improve treatment, and support better outcomes. 

That is why AdvaMed’s 2026 Patients First Agenda focuses on supporting policies that put patients at the center of health care. Across the country, AdvaMed works alongside patient advocacy group partners to help address gaps in access and coverage for critical medical technologies and bring innovative care to patients and families when they need it most.

BOSTON, MA, UNITED STATES, May 26, 2026 /EINPresswire.com/ — UltraSight™, a leader in AI-guided cardiac imaging, today announced publication of a multicenter peer-reviewed study in European Heart Journal – Digital Health showing clinicians with no prior ultrasound experience achieved diagnostic-quality cardiac ultrasound images in 97.7% of cases after a single day of AI-guided training.

BOSTON, MA, UNITED STATES, May 19, 2026 /EINPresswire.com/ — UltraSight™, a leader in AI-guided cardiac imaging, today announced the appointment of Rick Geoffrion as Chairman of the Board. Mr. Geoffrion brings more than 35 years of medical technology leadership experience, including more than 30 years in the cardiovascular space, spanning interventional cardiology, circulatory support, structural heart, and medical device commercialization.